Phase 2 FLAVOR clinical trial currently enrolling 150 patients to assess the safety and effectiveness of CYR-064 in treating patients with chronic smell loss following recovery from a viral infection
Alzheimer s Drug Discovery Foundation Joins Astrocyte Pharmaceuticals $6M Pre-Series B Financing Round to Expand Development of Cerebroprotectant AST-004 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.